Human Umbilical Cord-derived Mesenchymal Stem Cells for Decompensated Cirrhosis (MSC-DLC-1)

Clinical trial NCT05227846 · UNKNOWN

Trial details

NCT number: NCT05227846
Sponsor: Beijing 302 Hospital
Status: UNKNOWN
Phase: Phase 1
Study type: INTERVENTIONAL

Decompensated Cirrhosis

Start date: 2022-03-22
Primary completion: 2024-06-30
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.